治疗高合并症负担患者是否越来越昂贵?2013年至2021年全膝关节置换术的财务趋势
在一家大型城市学术医疗中心2013年至2021年共14,978例全膝关节置换术(TKA)中,回顾性分析1,156例高合并症负担(HCB,Charlson合并症指数≥5且美国麻醉医师协会评分3或4分)且财务数据完整的患者。结果显示HCB TKA占比从2013年4.2%升至2021年16.5%(P<.001),收入保持稳定(P=.093),直接成本显著增加32.0%(P=.015),边际贡献降至2013年水平的低点82.3%。
要点
- HCB患者TKA占比从2013年4.2%升至2021年16.5%(P<.001)。
- HCB TKA收入保持稳定(P=.093),直接成本显著增加32.0%(P=.015)。
- 边际贡献降至2013年水平的低点82.3%,90天并发症或居家出院率无显著变化。
核心结论
- HCB患者TKA成本大幅上升而收入未相应增加,支付未充分反映患者复杂性,作者认为有必要重新评估对医学复杂TKA患者的机构支付以维持需求人群的可及性。
研究设计与样本
- 回顾性分析一家大型城市学术医疗中心2013年至2021年共14,978例TKA中1,156例HCB(Charlson合并症指数≥5且美国麻醉医师协会评分3或4分)且财务数据完整的患者。
主要发现
- HCB TKA占比从2013年4.2%升至2021年16.5%(P<.001)。
- HCB TKA收入保持稳定(P=.093),直接成本显著增加32.0%(P=.015)。
- 边际贡献降至2013年水平的低点82.3%。
- 研究期间90天并发症率或居家出院率无显著变化。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Utilization of total knee arthroplasty (TKA) continues to rise among patients who have a high comorbidity burden (HCB). With changes in reimbursement models over the past decade, it is essential to assess the financial impact of HCB TKA on healthcare systems. This study aimed to examine trends in revenue and costs associated with TKA in HCB patients over time. METHODS: Of 14,978 TKA performed at a large, urban academic medical center between 2013 and 2021, we retrospectively analyzed HCB patients (Charlson comorbidity index ≥ 5 and American Society of Anesthesiology scores of 3 or 4). A total of 1,156 HCB TKA patients who had complete financial data were identified. Patient demographics, perioperative data, revenue, costs, and contribution margin were collected for each patient. Changes in these financial values over time, as a percentage of 2013 values, were analyzed. Linear regression was performed with a trend analysis to determine significance. RESULTS: From 2013 to 2021, the percentage of HCB TKAs per year increased from 4.2% in 2013 to 16.5% in 2021 (P < .001). The revenue of TKA in HCB patients remained steady (P = .093), while direct costs increased significantly (32.0%; P = .015), resulting in a decline of contribution margin to a low of 82.3% of 2013 margins. There was no significant change in rates of 90-day complications or home discharge following HCB TKA during the study period. CONCLUSIONS: The results of this study indicate a major rise in cost for TKA among HCB patients, without a corresponding rise in revenue. As more patients who have HCB become candidates for TKA, the negative financial impact on institutions should be considered, as payments to institutions do not adequately reflect patient complexity. A re-evaluation of institutional payments for medically complex TKA patients is warranted to maintain patient access among at-need populations.
引用
- Thomas J, Ashkenazi I, Katzman JL, et al. Is It Getting More Expensive to Treat Patients Who Have a High Comorbidity Burden? Financial Trends in Total Knee Arthroplasty From 2013 to 2021. J Arthroplasty. 2024. PMID: 38677344. doi:10.1016/j.arth.2024.04.055
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。